Drugs / C-1101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07264270 | Dec 2025 → Nov 2026 expected | radiculopathy, sciatica | Consano Bio | Recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 5
| Date | Issuer | Release |
|---|---|---|
| 2026-09-10 | Consano Bio | Results Consano Bio Announces Peer-Reviewed Publication Supporting the Therapeutic Potential of C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica consanobio.com ↗
Research published in Frontiers in Bioengineering and Biotechnology demonstrated C 1101 reduced inflammation and tissue breakdown while activating repair pathways — acting on the disease, not just the pain — in a nonclinical study |
| 2026-08-18 | Consano Bio | Regulatory Consano Bio Receives FDA Fast Track Designation for C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica consanobio.com ↗ |
| 2026-07-20 | Consano Bio | Regulatory Consano Bio Receives FDA Investigational New Drug Clearance to Expand the C-1101 Chronic Sciatica Clinical Development Program into the United States consanobio.com ↗
The IND clearance authorizes expansion of Consano Bio’s ongoing Phase 1 clinical trial to include U.S. clinical sites, complementing the study currently underway in Australia. |
| 2026-03-30 | Consano Bio | Results Consano Bio Presents Preclinical Data on C-1101 at ORS 2026 Annual Meeting consanobio.com ↗
Results demonstrated anti-inflammatory effects of C-1101 in activated human immune cells. |
| 2025-11-19 | Consano Bio | Results Consano Bio Presents Favorable Nonclinical Safety Results for C-1101 at the American College of Toxicology 46th Annual Meeting consanobio.com ↗
In the 28-day GLP toxicology study conducted in rats, C-1101 was well tolerated after single and repeat epidural administration of C-1101 at all dose levels tested. |
All press releases naming this drug 8 releases
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-1101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07264270 ↗ |
| Route | Other | “transforaminal epidural injection” NCT07264270 ↗ |